Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progress and novel discoveries in biliary tract diseases.
Vleggaar FP, van Berge-Henegouwen GP. Vleggaar FP, et al. Among authors: van berge henegouwen gp. Eur J Gastroenterol Hepatol. 1999 Jan;11(1):47-50. doi: 10.1097/00042737-199901000-00010. Eur J Gastroenterol Hepatol. 1999. PMID: 10495172 Review. No abstract available.
Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
van Hoogstraten HJ, Vleggaar FP, Boland GJ, van Steenbergen W, Griffioen P, Hop WC, van Hattum J, van Berge Henegouwen GP, Schalm SW, van Buuren HR. van Hoogstraten HJ, et al. Among authors: van hattum j, van buuren hr, van berge henegouwen gp, van steenbergen w. Am J Gastroenterol. 2000 Aug;95(8):2015-22. doi: 10.1111/j.1572-0241.2000.02267.x. Am J Gastroenterol. 2000. PMID: 10950051 Clinical Trial.
Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
van de Meeberg PC, Wolfhagen FH, Van Berge-Henegouwen GP, Salemans JM, Tangerman A, van Buuren HR, van Hattum J, van Erpecum KJ. van de Meeberg PC, et al. Among authors: van hattum j, van buuren hr, van erpecum kj, van berge henegouwen gp. J Hepatol. 1996 Dec;25(6):887-94. doi: 10.1016/s0168-8278(96)80293-5. J Hepatol. 1996. PMID: 9007717 Clinical Trial.
A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group.
Van Hoogstraten HJ, De Smet MB, Renooij W, Breed JG, Engels LG, Den Ouden-Muller JW, Rijk MC, Smit AM, Zwertbroek R, Hop WC, van Berge Henegouwen GP, Schalm SW, van Buuren HR. Van Hoogstraten HJ, et al. Among authors: van buuren hr, van berge henegouwen gp. Aliment Pharmacol Ther. 1998 Oct;12(10):965-71. doi: 10.1046/j.1365-2036.1998.00395.x. Aliment Pharmacol Ther. 1998. PMID: 9798800 Clinical Trial.
No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study.
Vleggaar FP, van Buuren HR, van Berge Henegouwen GP, Hop WC, van Erpecum KJ. Vleggaar FP, et al. Among authors: van buuren hr, van erpecum kj, van berge henegouwen gp. Eur J Gastroenterol Hepatol. 2001 Feb;13(2):171-5. doi: 10.1097/00042737-200102000-00013. Eur J Gastroenterol Hepatol. 2001. PMID: 11246617 Clinical Trial.
Therapy with ursodeoxycholic acid in cholestatic liver disease.
Van de Meeberg PC, van Erpecum KJ, van Berge-Henegouwen GP. Van de Meeberg PC, et al. Among authors: van erpecum kj, van berge henegouwen gp. Scand J Gastroenterol Suppl. 1993;200:15-20. doi: 10.3109/00365529309101569. Scand J Gastroenterol Suppl. 1993. PMID: 8016564 Review.
292 results